Laurie Toich, Assistant Editor

Testing method could improve radioembolization technique in cancer treatment.

Removing proteins from the surface of secretory granules can potentially prevent anaphylactic shock.

Variants identify areas of the genome associated with multiple sclerosis.

Top news of the day from across the healthcare landscape.

The nomogram can predict risk of readmission to the surgical intensive unit.

Descovy showed non-inferiority to Truvada, and benefited bone and kidney health.

Older patients understood medication information more if it included pictograms.

Vaccine candidates for hepatitis C virus have been notoriously unsuccessful in preventing the infection.

Astellaas Pharma has entered into an agreement to acquire Ganymed and its investigational cancer antibodies.

Triolimus contains paclitaxel plus 2 agents to prevent chemotherapy resistance.

Injections of nanoliposomes reversed memory loss associated with Alzheimer’s disease in mouse models.

Top news of the day from across the healthcare landscape.

Xgeva targets the RANK ligand pathways to prevent the creation, function, and survival of osteoclasts.

A new report finds that employee contributions to health insurance premiums and deductibles are growing slowly, but individuals have been using a larger portion of their incomes to do so.

Novel PCSK9 inhibitor bococizumab halted after manufacturer determines limited value.

The bococizumab development program and all trials will be discontinued.

Eli Lilly and Company will launch a revised version of a tool that tracks the progress of cancer over time.

Amgen announces top-line results from trial evaluating Xgeva in multiple myeloma.

Ibalizumab caused 83% of HIV-positive patients to achieve a virologic response.

LipidSeq can lead to more effective treatments for patients with high cholesterol.

Presentations and discussions will be held at colleges to combat the opioid epidemic.

Top news of the day from across the healthcare landscape.

Premiums in employer plans are growing more slowly on average, as are individual income levels.

Americans are spending a larger portion on employer-sponsored premiums and deductibles.

Ribociclib treats patients with HR+/HER2- advanced or metastatic breast cancer.

NTRX-07 reduced inflammation and improved cognition in animal studies.

Experimental drug treats patients with HR+/HER2- advanced or metastatic breast cancer.

A new trial investigates the use of Lambda in patients with hepatitis D virus.

A method to detect underwater structure damage could be used to detect breast cancer.

Top news of the day from across the healthcare landscape.